Arcutis Biotherapeutics, Inc. | License Agreements | Business Contracts

License Agreement, dated July 23, 2018, by and between AstraZeneca AB and the Registrant (Filed With SEC on January 6, 2020)

Exclusive Option and License Agreement, dated January 4, 2018, by and between Jiangsu Hengrui Medicine Co., Ltd. and the Registrant (Filed With SEC on January 6, 2020)

Option Notice and Amendment No. 2 to Exclusive Option and License Agreement, dated December 5, 2019, by and between Jiangsu Hengrui Medicine Co., Ltd. and the Registrant (Filed With SEC on January 6, 2020)

Arcutis Biotherapeutics, Inc. (52) | License Agreements (3)